Medicare Will Stop Covering This Essential Service in Less Than a Week

CMS will end broad Medicare telehealth waivers effective Jan. 31, 2026 (waivers in place since March 6, 2020), restricting coverage to narrow circumstances: behavioral health, rural beneficiaries, telehealth conducted in a medical facility, home dialysis for ESRD, and acute stroke evaluation/treatment. The change will remove coverage for telehealth for the majority of traditional Medicare beneficiaries, likely shifting costs to retirees or prompting moves into Medicare Advantage plans that retain telehealth benefits, and could modestly pressure revenue prospects for telehealth-focused providers that rely on Medicare volumes.

Analysis

Market structure: The CMS rollback (effective Jan 31, 2026) shifts payment from broad fee-for-service telehealth to narrow use cases (behavioral health, rural, facility-based, ESRD, acute stroke). Expect direct winners: Medicare Advantage payors (UNH, HUM, CVS/AET) who can re-price plans to include telehealth, and home-dialysis and behavioral-health specialists (DVA/FMS exposure to dialysis; ACHC, TDOC’s behavioral unit). Direct losers: pure-play virtual care platforms (TDOC, AMWL) that derived a material share of growth from traditional Medicare; estimate a 50–70% drop in Medicare-covered telehealth volumes for traditional Medicare beneficiaries absent MA substitution over the next 6–12 months.

Risk assessment: Tail risks include Congressional or CMS reversals if access complaints intensify (6–12 month horizon) or state-level telehealth parity laws that preserve payment (short-term 0–3 months). Operational risks: smaller telehealth providers face cash-burn shocks and covenant stress, causing credit spreads to widen by 200–500bps on weaker issuers. Catalysts: 2026 MA plan designs (announced Oct–Dec 2026) and Q1 2026 utilization data (Mar–Apr 2026) will confirm migration rates; monitor CMS guidance and litigation filings in next 30 days.

Trade implications: Favor long exposure to large MA insurers (UNH, HUM) via 6–12 month calls or buy-and-hold (1–2% portfolio each) to capture plan repricing; add tactical long to dialysis services (DVA, FMS) 0.5–1% as ESRD telehealth remains covered. Short small-cap telehealth providers (AMWL, TDOC small size) via 3–6 month put spreads sized 1–2% notional; expect 20–40% downside if Medicare volumes collapse and MA uptake is slow. Credit: buy protection (CDS or bond puts) on weakest telehealth credits and take profits on tech defensives like ZM which may see a modest re-rate.

Contrarian angles: Consensus assumes permanent secular loss for telehealth; that may be overdone if MA adoption is slow—policy pushback or new CPT codes could restore coverage partially by mid-2026. Also behavioral health remains a durable telehealth category — specialists with >50% behavioral revenue could be underpriced. Historical parallel: post-pandemic state-level rollbacks saw partial repeal and hybrid recovery; a 30–50% rebound in visits is plausible within 12–24 months if lobbying succeeds. Monitor MA enrollment shifts, CMS Q1 utilization, and pending litigation as three binary events that can flip market direction quickly.

Key Decisions for Investors

• Establish a 1–2% short position (notional) in pure-play telehealth equities: buy 3–6 month put spreads on AMWL and TDOC (e.g., buy ATM put, sell 20–30% lower strike) to capitalize on an expected 20–40% downside if Medicare volumes drop 50–70% among traditional beneficiaries.
• Deploy 1–2% long exposure to Medicare Advantage leaders UNH and HUM via outright shares or 9–12 month call spreads (UNH, HUM) to capture plan-design migration and pricing power; target entry before Oct 2026 MA plan announcements and add on any >5% post-announcement weakness.
• Allocate 0.5–1% to dialysis/service providers DVA and FMS (buy shares) because ESRD telehealth remains covered; use 6–12 month horizon to realize a 10–25% upside if utilization shifts to home dialysis services.
• Reduce/avoid small-cap telehealth credit and equity exposure: sell or hedge bonds of telehealth issuers with >50% Medicare revenue or negative EBITDA; target credit-spread widening of 200–500bps as a trigger to increase hedges within 30 days.
• Monitor three binary catalysts (within next 30–120 days): CMS technical guidance/litigation outcomes, MA plan benefit filings (Oct–Dec 2026), and Q1 2026 Medicare utilization data. If any catalyst indicates policy reversal or MA fails to substitute volumes, trim shorts and reallocate 50% into behavioral-telehealth specialists (ACHC, TDOC behavioral unit).